Back
Recursion Pharmaceuticals Vs. Marinus Pharmaceuticals Industry Stock Comparison
Buy
74
RXRX
Recursion Pharmaceuticals
Last Price:
9.42
Seasonality Move:
66.82%
Sell
31
MRNS
Marinus Pharmaceuticals
Last Price:
1.33
Seasonality Move:
0.67%
Buy
74
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $9.42. The Score for RXRX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.33. The Score for MRNS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $9.42
The current trend is moderately bullish and RXRX is experiencing slight buying pressure.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.
RXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 56.02 | Buy |
| Chaikin Money Flow: | 1036064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.64 - 9.22) | Buy |
| Bollinger Bands (100): | (8.49 - 11.93) | Sell |
MRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 19.15 | Sell |
| Chaikin Money Flow: | -325242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.48) | Sell |
| Bollinger Bands (100): | (3.94 - 11.16) | Sell |
RXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.29 | Buy |
| 20-day SMA: | 8.66 | Buy |
| 50-day SMA: | 9.2 | Buy |
| 200-day SMA: | 8.98 | Buy |
| 8-day EMA: | 9.35 | Buy |
| 20-day EMA: | 8.98 | Buy |
| 50-day EMA: | 9.23 | Buy |
| 200-day EMA: | 9.26 | Buy |
MRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.35 | Sell |
| 20-day SMA: | 1.41 | Sell |
| 50-day SMA: | 5.07 | Sell |
| 200-day SMA: | 7.43 | Sell |
| 8-day EMA: | 1.37 | Sell |
| 20-day EMA: | 1.97 | Sell |
| 50-day EMA: | 4.18 | Sell |
| 200-day EMA: | 6.98 | Sell |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.25 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.15 per share.
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.23 per share, an increase this year of $0.56 per share, and an increase next year of $0.84 per share.
Recursion Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Marinus Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||